Global Bioprocess Analyzers Market Size study & Forecast, by Product (Instrument and Consumables), Application (Antibiotics, Recombinant Proteins, Biosimilars, Other Applications), Type (Substrate Analysis, Metabolite Analysis, and Concentration Detection

Global Bioprocess Analyzers Market Size study & Forecast, by Product (Instrument and Consumables), Application (Antibiotics, Recombinant Proteins, Biosimilars, Other Applications), Type (Substrate Analysis, Metabolite Analysis, and Concentration Detection), and Regional Analysis, 2022-2029

Global Bioprocess Analyzers Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.1% over the forecast period 2022-2029. Bioprocess Analyzers help in the quick analysis of many properties with rapid measurement of the whole bioprocess. The Bioprocess Analyzers market is expanding because of factors such as growing interest in the development of advanced medicines and vaccines and increasing demand for biologics. This market is dominated by F. Hoffmann-La Roche AG, Nova Biomedical Corporation, YSI Inc., and Randox Laboratories Ltd.

This market has been seeing significant growth in the past few years due to the growing interest from fields such as pharmacology, toxicology, and biotechnology in the development of advanced pharmaceutical products and vaccines, and rising demand for mammalian protein production are also major factors driving the growth of the market. As recombinant proteins, they are used not only in biomedical research but also in therapy and are in increasing demand as pharmaceuticals and are increasing with production. In addition, Recombinant Protein is expected to increase the opportunity for this significant market. However, the technical issues and cost factor may stifle the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Bioprocess Analyzers Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. In December 2021, the alliance of public and private organizations helping create a progressive pharmaceutical cluster in central Virginia has been named a finalist in the Economic Development Authority's (EDA) $1 billion Build Back Better Regional Challenge campaign. This alliance is expected to advance the development and expansion of the advanced pharmaceutical industry in central Virginia. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.


Major market player included in this report are:
F. Hoffmann-La Roche Ltd
Sartorious AG
Agilent Technologies India Pvt Ltd
YSI Inc.
Randox Laboratories Ltd
Thermo Fisher Scientific Inc
Nova Biomedical Corporation
Polestar Technologies
Groton Biosystems

Recent Developments in the Market:
 In June 2019, Biogenuix Medsystems Private Limited launched Cypher One, an automated heme agglutination analyzer, a high-throughput, one-step solution for rapid and automated analysis of heme aggregation (HA) and heme inhibition (HAI) assays. has been released.
 In September 2021, Merck's Life Sciences business launched the ProCellics Raman Analyzer with Bio4C PAT Raman software. GMP-compliant platforms provide in-line and real-time monitoring of critical process parameters and critical cell culture quality attributes in upstream development and manufacturing of monoclonal antibody and vaccine processes. It is specially made for the bioprocessing industry.


Global Bioprocess Analyzers Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Application, Type, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Instrument
Consumable
By Application:
Antibiotics
Recombinant Proteins
Biosimilars
Other Applications
By Type:
Substrate Analysis
Metabolite Analysis
Concentration Detection

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

F. Hoffmann-La Roche Ltd
Sartorious AG
Agilent Technologies India Pvt Ltd
YSI Inc.
Randox Laboratories Ltd
Thermo Fisher Scientific Inc
Nova Biomedical Corporation
Polestar Technologies
Groton Biosystems

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.